Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 26, 2022
Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing-Remitting Multiple Sclerosis After Fingolimod WithdrawalFabien Rollot, Justine Couturier, Romain Casey, et al.
European Journal of Neurology|March 2, 2021
Untreated patients with multiple sclerosis: A study of French expert centersXavier Moisset, Audrey-Anne Fouchard, Bruno Pereira, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 15, 2024
Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis SocietyNicolas Collongues, Françoise Durand-Dubief, Christine Lebrun-Frenay, et al.
Multiple Sclerosis and Related Disorders|May 14, 2026
External validation and improvement of an algorithm that identifies multiple sclerosis relapses in the French national healthcare claims databaseLaure Carcaillon-Bentata, Abdelilah Abouelfath, Séverine Lignot-Maleyran, et al.
Neurology|September 25, 2024
Anti-CD20 Therapies in Drug-Naive Patients With Primary Progressive Multiple Sclerosis: A Multicenter Real-Life StudyMarion Hay, Fabien Rollot, Romain Casey, et al.
Advances in Therapy|February 19, 2025
LymphoTEC: a Retrospective Real-World Study on Lymphocyte Reconstitution After Lymphopenia in Patients with Multiple Sclerosis Treated with Dimethyl Fumarate in FranceJérôme de Sèze, Pierre Labauge, Roland Liblau, et al.
Neurology|July 30, 2025
Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple SclerosisAntoine Gavoille, Emmanuelle Leray, Romain Marignier, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 14, 2022
Improving the decision to switch from first- to second-line therapy in multiple sclerosis: A dynamic scoring systemCamille Sabathé, Romain Casey, Sandra Vukusic, et al.
JAMA Neurology|August 4, 2025
Therapeutic Management During Pregnancy and Relapse Risk in Women With Multiple SclerosisAntoine Gavoille, Fabien Rollot, Romain Casey, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 4, 2025
Target trial emulation to replicate randomised clinical trials using registry data in multiple sclerosisAntoine Gavoille, Mikail Nourredine, Fabien Rollot, et al.
Pageof 9